PARIS / ACCESSWIRE / March 21, 2023 / SFD 2023 - Diabeloop, a pioneer in Automated Insulin Delivery, will collaborate with leading global healthcare company, Novo Nordisk. The agreement covers ...
Novo Nordisk announced plans to make the durable, connected insulin pens NovoPen 6 and NovoPen Echo Plus commercially available across key markets commencing in early 2019. In parallel, to support the ...
GATWICK, England--(BUSINESS WIRE)--This material is intended for UK medical and pharmaceutical trade media only. For journalistic assessment and preparation before publication. People living with ...
First insulin injection device to combine half-unit dosing with a memory function to help patients better manage their diabetes This pen is the latest insulin delivery system from Novo Nordisk, and ...
Novo Nordisk has been working to make sure its upcoming connected insulin pens are compatible with the other diabetes-focused hardware on the market—including through a new collaboration with Abbott ...
At entry to the study 43 patients (61%) were using Novopen ® 3 to administer their insulin, 22 (31%) were using syringes, and five (7%) had used a combination of Novopen ® 3 and syringes. 43 (90%) ...
Novo Nordisk, a world leader in diabetes care, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its insulin device NovoPen Echo. This marks the first and only pen ...
Novo Nordisk has voluntarily recalled insulin cartridge holders used in six NovoPen Echo batches because they may crack or break if exposed to certain chemicals, like certain cleaning agents. Using a ...
On the occasion of the annual congress of the Société francophone du diabète (SFD), in Montpellier, March 21-24, Diabeloop announces a collaboration with Novo Nordisk, a major global healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback